· Original article
Cass earnings rise 16% as margin widens and dividend increases
Cass earnings rose 16.1% in Q3 2026 as interest income and payment fees grew. A higher dividend comes alongside rising technology costs and bond losses.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Read the original source and publication date in each article.
Results: 1,575 · Page 31 / 132
· Original article
Cass earnings rose 16.1% in Q3 2026 as interest income and payment fees grew. A higher dividend comes alongside rising technology costs and bond losses.
· Original article
HPCL earnings show Q2 FY27 profit of about ₹3,625 crore, down 6%, as fuel-marketing losses offset stronger refining margins and sales volumes rose.
· Original article
Nippon India AMC's September 2026 profit fell to ₹324 crore as a ₹97 crore settlement provision and weaker investment returns offset revenue growth.
· Original article
Muse downloads passed 10 million in the US within 40 days, giving Meta an early adoption milestone for its personal AI agent launched in September.
· Original article
FHLBank Atlanta earnings fell to $126 million in Q3 2026 as interest income declined. The bank declared a dividend at a 6.20% annualized rate.
· Original article
Goldman Sachs acquisition talks concern UK testing group Celnor at about £900 million, as the firm seeks to expand its asset management business.
· Original article
Goldman Sachs lowered its MAA price target to $125 from $142 on October 19, 2026, while retaining a Neutral rating on the apartment REIT.
· Original article
Toyota's Land Cruiser recall covers 105,794 US hybrids from model years 2024–2027, with free repairs planned for a fuel connection fault.
· Original article
Ally price target falls to $48 from $56 at Barclays, while its Equal-Weight rating remains unchanged in the October 21, 2026 analyst update.
· Original article
Nippon Life settlement receives in-principle SEBI approval after a ₹96.76 crore payment in the Yes Bank bond case; a formal order remains pending.
· Original article
Xona funding values the satellite navigation company at $2.45 billion as it expands manufacturing and targets initial customer service in 2027.
· Original article
Batoclimab approval in China clears a treatment for adult gMG patients, with CSPC subsidiary NBP Pharma handling sales and Harbour receiving royalties.
Charts and market data by TradingView. Availability and delays vary by exchange.